🔗 Share this article

As America continues making sweeping adjustments to its vaccination recommendations, a particular individual has emerged unexpectedly: Tracy Beth Høeg, an American of Danish descent sports medicine doctor and public health researcher who first made her name by casting doubt on COVID-19 vaccinations in the global health crisis and has concentrated on possible fatalities after COVID-19 vaccination in her brief time at the FDA.

Scheduled Shifts to Childhood Vaccine Program

Health officials planned to unveil radical changes to the childhood vaccination calendar earlier this month, aligning the US with Denmark’s vaccine program, according to reports – a major change that would put the US at odds with many the global community with insufficient data for benefit. This reveal has been delayed until the next year.

Instead of Vinay Prasad, Dr. Høeg is listed to address the audience at the event. She was newly appointed interim head of the FDA’s CDER, the fifth individual to head the center this year.

A Shift at the Regulatory Body

Høeg's temporary position may indicate a tighter collaboration between the drug and vaccine branches as Høeg and Dr. Prasad consolidate power at the agency – and it signals a increased emphasis upon dismantling long-standing vaccines at the FDA.

Høeg has repeatedly called for ending certain pediatric immunization guidelines in the US to become more in line with the Danish model, a country with nationalized medicine and a number of inhabitants roughly the population of the state of Wisconsin.

In her initial public appearances, she has kept her attention on vaccination policy – traditionally the purview of Prasad, director of the FDA’s Center for Biologics Evaluation and Research (CBER) – as opposed to drug regulation.

Questions Over Expertise

Høeg has no obvious background in drug development, regulation or administrative roles, which has been customary for past heads of the CBER. She has been employed at the FDA as a senior adviser to the FDA chief and CBER since earlier this year.

“It seems she lacks to have any of the qualifications” for leading the pharmaceutical oversight division, stated a neurologist and psychiatrist. “She has not conducted a scientific study. She lacks experience in managing a large organization. She is not an expert in drug approvals.”

Former commissioners of the center would “understand legal statutes and the underlying principles of medication creation”, commented Janet Woodcock. “Frankly, she has not acquired the type of experience that previous people who led CBER have had.”

The drug center has an enormous range of responsibilities at the agency, Woodcock emphasized.

“The public just focuses on the new drug program, but the off-patent medication office authorizes a multitude of generic drugs. There is also a biologic copycat branch, over-the-counter program and so forth, and each of these have to be supervised,” Woodcock explained. “The responsibility you don’t keep your eye on, that is precisely what that I always told people is going to come back to haunt you.”

Additionally, a significant management component to the job, which manages more than 5,000 staff members. “It’s a huge administrative position, if you execute it properly,” the former official added.

Agency Reaction and Contentious Policies

When asked about inquiries about Høeg’s credentials and whether this assignment represents greater collaboration among agency officials on immunizations, a press secretary said that the “questions are based on inaccurate assumptions”.

“This background is consistent with the responsibilities of her job,” the representative stated, noting the time Høeg spent counseling the agency head on “medication safety and oversight research, including computational safety modeling and immunization monitoring”.

As acting director, Dr. Høeg inherits the agency head's recently launched expedited review system, a contentious rapid drug-approval program that reportedly troubled her former heads. “How are these medications being selected for this fast-track system? Who makes the calls?” Dr. Howard asked. “There is a lot of secrecy going on at the regulatory body right now.”

Broadly speaking, he said, “the agency appears to be shifting towards laxer regulations of most medications, except for vaccines.”

Established History on Vaccines

Concerning immunizations, Høeg has a more established, if concerning, past, Howard observe. She published a study using unconfirmed volunteer-provided data to estimate the incidence of myocarditis following Covid immunization. She advised the Florida chief medical officer Joseph Ladapo, who was said to have modified findings to suggest Covid vaccines are pose a greater threat than they are.

Part of her “wish list” for the new government encompassed altering guidelines for novel immunizations and halting “unnecessary” immunizations, she remarked following the vote on a audio program. At the agency, Dr. Høeg has reportedly floated the idea of preventing young men from getting Covid vaccinations.

“She is an all-around true believer who commences with her preconceived notions and reverse-engineers to fit the science in a highly misleading, fraudulent way,” Dr. Howard stated.

Gaining Influence and a “Revenge Tour”

Høeg became part of fellow contrarians, {like|